Literature DB >> 4611586

Letter: Treatment of recurrent aphthous stomatitis and herpes with levamisole.

J Symoens, J Brugmans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4611586      PMCID： PMC1612743          DOI： 10.1136/bmj.4.5944.592

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  7 in total

1.  Letter: Levamisole for recurrent herpes labialis.

Authors:  A Kint; L Verlinden
Journal:  N Engl J Med       Date:  1974-08-08       Impact factor: 91.245

2.  Letter: Treatment of aphthous stomatitis.

Authors:  H Verhaegen; J De Cree; J Brugmans
Journal:  Lancet       Date:  1973-10-13       Impact factor: 79.321

3.  Levamisole and cell-mediated immunity.

Authors:  W H Churchill; J R David
Journal:  N Engl J Med       Date:  1973-08-16       Impact factor: 91.245

4.  Influence of tetramisole and its optical isomers on the mononuclear phagocytic system. Effect on carbon clearance in mice.

Authors:  J Hoebeke; G Franchi
Journal:  J Reticuloendothel Soc       Date:  1973-09

5.  Augmentation of chemotherapeutically induced remission of a murine leukemia by a chemical immunoadjuvant.

Authors:  M A Chirigos; J W Pearson; J Pryor
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

6.  Restoration of host defense mechanisms in man by levamisole.

Authors:  J Brugmans; V Schuermans; W De Cock; D Thienpont; P Janssen; H Verhaegen; L Van Nimmen; A C Louwagie; E Stevens
Journal:  Life Sci       Date:  1973-12-01       Impact factor: 5.037

7.  Stimulation of anti-Brucella vaccination in mice by tetramisole, a phenyl-imidothiazole salt.

Authors:  G Renoux; M Renoux
Journal:  Infect Immun       Date:  1973-10       Impact factor: 3.441
  7 in total
  15 in total

1.  Treatment with levamisole of recurrent herpes genitalis.

Authors:  T W Chang; N Fiumara
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

2.  Leukocyte migration inhibitory factor in primary and recurrent ocular infections by herpes simplex-virus.

Authors:  G Grabner; R Jarisch
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1979-07-02

Review 3.  Cell-mediated immunity and its role in resistance to infection.

Authors:  E J Wing; J S Remington
Journal:  West J Med       Date:  1977-01

4.  Therapeutic aspects of herpes genitalis. A short review.

Authors:  J Söltz-Szöts; D Fanta
Journal:  Br J Vener Dis       Date:  1979-04

5.  Treatment of recurrent herpes simplex labialis with levamisole.

Authors:  S L Spruance; G G Krueger; J MacCalman; J C Overall; M R Klauber
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

6.  Inhibition of the E-rosette formation of T-lymphocytes by aggregated human IgG and restoration by levamisole.

Authors:  W De Cock; J De Cree; H Verhaegen
Journal:  Immunology       Date:  1978-08       Impact factor: 7.397

7.  Restoration by levamisole of low E-rosette forming cells in patients suffering from various diseases.

Authors:  H Verhaegen; J De Cree; W De Cock; F Verbruggen
Journal:  Clin Exp Immunol       Date:  1977-02       Impact factor: 4.330

8.  Levamisole in aphthous stomatitis: evaluation of three regimens.

Authors:  J D Meyer; M Degraeve; J Clarysse; F De Loose; W Peremans
Journal:  Br Med J       Date:  1977-03-12

9.  Effects of levamisole on normal and abnormal leukocyte locomotion.

Authors:  D G Wright; C H Kirkpatrick; J I Gallin
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

10.  Controlled therapeutic trial of levamisole and sulphasalazine in acute ulcerative colitis.

Authors:  A Hermanowicz; A Nowak; L Gajos
Journal:  Gut       Date:  1984-05       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.